COL22A1 expression identifies aggressive glioma and independently predicts survival through integrated multiomics and clinical validation
{{output}}
Background: Gliomas, especially IDH‑wildtype astrocytomas, remain lethal despite multimodal therapy. Collagen type XXII alpha-1 (COL22A1) exhibits oncogenic activity in other cancers but remains underexplored in brain tumors. We... ...
